Evotec SE (EVO) Consolidated Net Income (2009 - 2025)

Evotec SE (EVO) reported Consolidated Net Income of -$120.4 million for Q4 2025, up 42.5% on a YoY basis from -$84.5 million in Q4 2024, and down 240274.03% sequentially from -$50074.1 in Q3 2025.

Evotec SE (EVO) Consolidated Net Income (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of Consolidated Net Income data on file, last reported at -$120.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Consolidated Net Income rose 42.5% year-over-year to -$120.4 million; the trailing twelve-month figure through Mar 2026 stood at -$120.4 million (up 42.49% YoY), and the FY2025 full-year result was -$120.5 million, up 42.49% from the prior year.
  • Consolidated Net Income declined to -$120.4 million in Q4 2025, from -$50074.1 in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $246.3 million in Q4 2021 to a low of -$209.3 million in Q4 2024.
  • A 5-year average of -$23.5 million and a median of -$22125.4 in 2022 frame the typical range for Consolidated Net Income.
  • Across the five-year window, Consolidated Net Income soared 8771.52% in 2021 and plunged 361.5% in 2024, its largest moves.
  • Tracing EVO's Consolidated Net Income over 5 years: stood at $246.3 million in 2021, then sank by 172.83% to -$179.3 million in 2022, then surged by 49.68% to -$90.2 million in 2023, then sank by 131.96% to -$209.3 million in 2024, then surged by 42.5% to -$120.4 million in 2025.
  • Business Quant data shows EVO's Consolidated Net Income at -$120.4 million in Q4 2025, -$50074.1 in Q3 2025, and -$209.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -120.37 Mn
Sep 30, 2025 -50,074.14
Dec 31, 2024 -209.31 Mn
Sep 30, 2024 -59,430.15
Dec 31, 2023 -90.24 Mn
Sep 30, 2023 22,726.50
Jun 30, 2023 -13,888.14
Dec 31, 2022 -179.34 Mn
Sep 30, 2022 39,779.45
Jun 30, 2022 -22,125.42
Mar 31, 2022 -72,868.90
Dec 31, 2021 246.25 Mn
Sep 30, 2021 160,102.41
Jun 30, 2021 73,489.46
Mar 31, 2021 68,554.02
Dec 31, 2020 7.47 Mn
Sep 30, 2020 1,804.68
Dec 31, 2019 41.30 Mn
Sep 30, 2010 1,282.23
Jun 30, 2010 2,369.92